Editor’s Note December 27, 2012
Written on Dec 27, 2011
With a new year upon us, we are reminded of the year that is now coming to a close. 2011 has brought some amazing advancements in the healthcare and life science industry. OneMedForum SF 2012 is just around the corner and we are gearing up to present some of the most promising companies and technologies,...
Editor’s Note December 20, 2012
Written on Dec 19, 2011
With a new year upon us, we are reminded of the year that is now coming to a close. 2011 has brought some amazing advancements in the healthcare and life science industry. OneMedForum SF 2012 is just around the corner and we are gearing up to present some of the most promising companies and technologies,...
Editor’s Note December 13, 2011
Written on Dec 13, 2011
With the holidays approaching, we are reminded of the year that is now coming to a close. 2011 has brought some amazing advancements in the healthcare and life science industry. OneMedForum SF 2012 is just around the corner and we are gearing up to present some of the most promising companies and...
Editor’s Note December 6, 2011
Written on Dec 6, 2011
Temperatures are dropping but things are heating up in the healthcare and life science industry. OneMedForum SF 2012 is around the corner and we are gearing up to present some of the most promising companies and technologies, as well as innovative approaches to funding the growth economy. In this...
WNDM to Acquire Medical Device Distributor Juventas; Bryant Gaines Named WNDM COO Effective Immediately
Written on Dec 1, 2011
Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leader in the advanced wound care solutions market, today announced that it had signed a letter of intent (LOI) to acquire Juventus LLC. Fort Worth, TX-based Juventas, controlled by former Biomet Texas affiliates Bryant Gaines and Jeff Ott,...
Editor’s Note November 29, 2011
Written on Nov 29, 2011
OneMedForum SF 2012 is around the corner and we are gearing up to present some of the most promising companies and technologies, as well as innovative approaches to funding the growth economy. In this issue:
EpiCept Corporation [EPCT.PK]will present its Cancer product, Ceplene, approved in the European Union...
